Elcoin: Blockchain-Based Medical Data Sharing Platform

Overview of Information about the Elcoin Project

Hello friends! Today, let’s talk about a project called “Elcoin.” In the blockchain world, it’s not uncommon to find projects with similar names, so first, it’s important to clarify that we’ve found two different entities online under the name “Elcoin,” which seem to refer to two distinct entities. One is “Elcoin (EL)” as a cryptocurrency, and the other is a fintech solutions provider called “Elcoin Ltd.”

Since you’re interested in a “new blockchain project” and mentioned “whitepaper” and “tokenomics,” we’ll focus mainly on the cryptocurrency-related “Elcoin (EL)” project, introducing it based on some early published materials. However, it’s important to note that information about this cryptocurrency project is relatively old, and it currently appears as “untracked” or “inactive” on several major crypto data platforms, meaning it may not be an active or developing new project. Therefore, we cannot provide a full whitepaper analysis for a “new project,” but will instead offer an overview based on available information.

Introduction to the Elcoin (EL) Cryptocurrency Project

What is Elcoin (EL)?
Elcoin (EL) is a cryptocurrency based on the Ethereum blockchain. You can think of it as a digital currency operating on Ethereum’s “public ledger.” Initially, it was positioned as a business tool aimed at attracting investment and developing new trading instruments.

Project Vision and Core Application (ELCoin Blockchain Medical Platform)
Among Elcoin-related materials, there is a project called the “ELCoin Blockchain Medical Platform,” which presents an ambitious vision: to connect doctors, medical professionals, and patients, building a decentralized platform for secure, fast, and transparent exchange and use of medical data.

You can imagine this platform as a “digital medical records room,” but instead of being controlled by a single hospital or company, it uses blockchain technology to give patients better control over their medical data. For example, patients can authorize different medical institutions (such as doctors, hospitals, labs, pharmacies, and insurance companies) to access their medical records under specific conditions. The goal is to address privacy, security, and interoperability issues found in traditional medical data management.

Technical Features
The technical core of this medical platform is the use of “Hyperledger Fabric.” Simply put, Hyperledger Fabric is an enterprise-grade blockchain framework, which differs from the fully public blockchains like Bitcoin or Ethereum. It is a “permissioned chain,” meaning not everyone can freely join the network—authorization is required. It’s like a private club where only members can enter. This design is especially suitable for scenarios requiring high privacy and permission control, such as medical data. It emphasizes auditability, transparency, and security of interactions, and allows patients to control who can view their records, how much they can see, and for how long.

Tokenomics (Early Information)
According to early information, the total supply of Elcoin (EL) is 20,935,289, with about 11,208,967 in circulation. However, some sources show its circulating supply as 0, with low market activity. The project conducted an initial coin offering (ICO) from January to June 2018, with an ICO price of about $3.92. The specific use of EL tokens within the medical platform, as described in the whitepaper, may include pharmaceutical companies paying tokens as compensation when users authorize access to their medical records.

Elcoin Ltd Fintech Company

In addition to the cryptocurrency project mentioned above, we also found an international IT company named “Elcoin Ltd.” Founded in 2017 and headquartered in the UK, with an R&D office in Latvia, it mainly provides fintech solutions for neobanks and marketplaces, including online banking, risk management, and API integration—a full suite of technical services. This company is more like a traditional software service provider, helping other financial institutions build and operate their digital financial services, rather than issuing its own public blockchain or cryptocurrency. Although their core banking engine supports crypto and NFT payments, this is part of their service offering, not their own blockchain project.

Common Risk Warnings

Given that information about the Elcoin (EL) cryptocurrency project is relatively outdated and its current market activity is low, the following risks exist:

• Low Project Activity: Many crypto data platforms mark it as “untracked” or “inactive,” which may indicate stalled development or insufficient community support.


• Liquidity Risk: If token trading volume is extremely low, investors may find it difficult to buy or sell, facing liquidity shortages.


• Lack of Transparency: The absence of up-to-date official whitepapers and detailed information makes it hard to fully assess the project’s current status and future potential.


• Technical and Security Risks: Although the early whitepaper mentioned Hyperledger Fabric, if the project is no longer maintained or updated, there may be unknown technical vulnerabilities and security risks.

Project Summary

In summary, the name “Elcoin” points to two different directions in the blockchain and fintech fields. If you’re interested in the cryptocurrency project “Elcoin (EL),” it was once an Ethereum-based token with an ambitious vision to solve medical data management issues through the “ELCoin Blockchain Medical Platform” using Hyperledger Fabric technology. However, information about the project is quite old, and the token is currently not very active. The other “Elcoin Ltd” is a fintech solutions provider, which differs from traditional blockchain cryptocurrency projects.

In the cryptocurrency space, project lifecycles can be short and technology evolves rapidly. Therefore, for any project—especially those with incomplete or inactive information—it’s recommended to conduct thorough independent research. The above information is only an overview based on existing public sources and does not constitute investment advice. Please be sure to do your own research (DYOR) and carefully assess risks.